tert-Butyl ((6-chloropyrazin-2-yl)methyl)carbamate

Catalog No. :
ACUYGF970
CAS No. :
1187222-00-9
Molecular Formula :
C10H14ClN3O2
Molecular Weight :
243.69

IUPAC Name:tert-butyl ((6-chloropyrazin-2-yl)methyl)carbamate

tert-Butyl ((6-chloropyrazin-2-yl)methyl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$86.00Login to see priceIn stockInquiry
1g97%$117.00Login to see priceInquiryInquiry
5g97%$424.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl ((6-chloropyrazin-2-yl)methyl)carbamate
IUPAC Nametert-butyl ((6-chloropyrazin-2-yl)methyl)carbamate
MDL No.MFCD20327987
Molecular FormulaC10H14ClN3O2
Molecular Weight243.69
SMILESO=C(OC(C)(C)C)NCC1=NC(Cl)=CN=C1
InChI KeyUOLVHJGYSHBODW-UHFFFAOYSA-N
Synonym(5-Hydroxymethyl-pyridin-2-yl)-carbamic acid tert-butyl ester;N-[(6-chloro-2-pyrazinyl)Methyl]-;Carbamic acid, N-[(6-chloro-2-pyrazinyl)methyl]-, 1,1-dimethylethyl ester
CAS No.1187222-00-9
PubChem CID77231610

Safety Data

Pictogram
Toxic
Signal Word
Gefahr
Hazard Statement(s)
H301-H311-H331
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P310-P330-P361-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACUYGF970 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACYUBZ203 route compound structure diagram
    ACYUBZ2036863-74-7 In Stock
  4. Then
  5. ACUYGF970 route product structure diagram
    ACUYGF9701187222-00-9 In Stock
Inquiry

2. ACUYGF970 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACXWTI379 route compound structure diagram
    ACXWTI3791357945-24-4 In Stock
  4. Then
  5. ACUYGF970 route product structure diagram
    ACUYGF9701187222-00-9 In Stock
Inquiry

Comments (0)